Aralkylaminopyrimidine compounds which are useful as for producing
申请人:Ube Industries, Ltd.
公开号:US04895849A1
公开(公告)日:1990-01-23
There are disclosed a compound represented by the formula: ##STR1## wherein R.sub.1 represents a hydrogen atom or a lower alkyl group; R.sub.2 and R.sub.3 each independently represent a halogen atom or a lower alkyl group; R.sub.4 represents a hydrogen atom, a halogen atom or a lower alkyl group; n represents an integer of 1 or 2; Q represents a phenyl group or a heterocyclic group; a substituted or unsubstituted alkyl group; an allyl group; a geranyl group; a farnesyl group; a cycloalkylmethyl group; a substituted ethyl group; a glycidyl group; an acetonyl group; a substituted dioxoranyl group; a 2,2-diethoxyethyl group, a 1-ethoxycarbonylethyl group, a trimethylsilylmethyl group or a 1-pyridylethyl group; A represents a lower alkylene group; and B represents a direct bond, an oxygen atom, a sulfur atom, a straight or branched lower alkylene group or a lower alkyleneoxy group; or an acid addition salt thereof, a process for producing the same, and an insecticide, an acaricide and a fungicide containing the derivative as the active ingredient.
[EN] AMINO-PYRIMIDONYL DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] DÉRIVÉS D'AMINO-PYRIMIDONYLE, PROCÉDÉ DE PRÉPARATION DE CEUX-CI ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
申请人:SERVIER LAB
公开号:WO2020008013A1
公开(公告)日:2020-01-09
Compounds of formula (I), wherein R1, R2, R3, R4, R5, R6, J and n are as defined in the description. Medicaments.
式(I)的化合物,其中R1、R2、R3、R4、R5、R6、J和n的定义如描述所示。药物。
N6-SUBSTITUTED ADENOSINE DERIVATIVES AND N6-SUBSTITUTED ADENINE DERIVATIVES AND USES THEREOF
申请人:Shi Jiangong
公开号:US20130045942A1
公开(公告)日:2013-02-21
The present invention provides N
6
-substituted adenosine derivatives and N
6
-substituted adenine derivatives, manufacturing methods thereof, a pharmaceutical composition comprising the said compounds above, and uses of these compounds in manufacturing medicaments and health-care products for treating insomnia, convulsion, epilepsy, and Parkinson's diseases, and preventing and treating dementia.
The present disclosure relates to methods of using transaminase polypeptides in the synthesis of chiral amines from prochiral ketones.
本公开涉及使用转氨酶多肽在合成手性胺类化合物中从原性酮中合成手性胺的方法。
[EN] CHEMICAL PROCESS FOR PREPARING SPIROINDOLONES AND INTERMEDIATES THEREOF<br/>[FR] PROCÉDÉ CHIMIQUE POUR LA PRÉPARATION DE SPIROINDOLONES ET INTERMÉDIAIRES CORRESPONDANTS
申请人:NOVARTIS AG
公开号:WO2013139987A1
公开(公告)日:2013-09-26
The present invention relates to processes and intermediates useful for the manufacture of spiroindolone compounds such as (1'R,3'S)-5,7'-dichloro-6'-fluoro-3'-methyl-2',3',4',9'-tetrahydrospiro[indoline-3,1'-pyrido[3, 4-b]indol]-2-one and salts and hydrates and solvates thereof.